CLINICAL_TRIALS
trial_result
· 2021-12-27
Clinical Trial Update: A Study of Modified Stem Cells in Traumatic Brain Injury (TBI) [Phase 2]
Summary
Phase 2 trial update on modified stem cells for traumatic brain injury has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SanBio, Inc. | Conditions: Traumatic Brain Injury | Phase 2 | Status: COMPLETED | Results posted: 2021-12-27